These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

270 related items for PubMed ID: 12632020

  • 1. Factor V Leiden mutation and PAI-1 gene 4G/5G genotype in thrombotic patients with Behcet's disease.
    Gurgey A, Balta G, Boyvat A.
    Blood Coagul Fibrinolysis; 2003 Feb; 14(2):121-4. PubMed ID: 12632020
    [Abstract] [Full Text] [Related]

  • 2. [Prevalence of thrombophilic mutations of FV Leiden, prothrombin G20210A and PAl-1 4G/5G and their combinations in a group of 1450 healthy middle-aged individuals in the Prague and Central Bohemian regions (results of FRET real-time PCR assay)].
    Kvasnicka J, Hájková J, Bobcíková P, Kvasnicka T, Dusková D, Poletínová S, Kieferová V.
    Cas Lek Cesk; 2012 Feb; 151(2):76-82. PubMed ID: 22515013
    [Abstract] [Full Text] [Related]

  • 3. Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis.
    Silingardi M, Salvarani C, Boiardi L, Accardo P, Iorio A, Olivieri I, Cantini F, Salvi F, La Corte R, Triolo G, Ciccia F, Ghirarduzzi A, Filippini D, Paolazzi G, Iori I.
    Arthritis Rheum; 2004 Apr 15; 51(2):177-83. PubMed ID: 15077257
    [Abstract] [Full Text] [Related]

  • 4. The association of factor V G1961A (factor V Leiden), prothrombin G20210A, MTHFR C677T and PAI-1 4G/5G polymorphisms with recurrent pregnancy loss in Bosnian women.
    Jusić A, Balić D, Avdić A, Pođanin M, Balić A.
    Med Glas (Zenica); 2018 Aug 01; 15(2):158-163. PubMed ID: 29703881
    [Abstract] [Full Text] [Related]

  • 5. Plasminogen activator inhibitor-1 4G/5G polymorphism, factor V Leiden, prothrombin mutations and the risk of VTE recurrence.
    Sundquist K, Wang X, Svensson PJ, Sundquist J, Hedelius A, Larsson Lönn S, Zöller B, Memon AA.
    Thromb Haemost; 2015 Nov 25; 114(6):1156-64. PubMed ID: 26245493
    [Abstract] [Full Text] [Related]

  • 6. Allele 4G of gene PAI-1 associated with prothrombin mutation G20210A increases the risk for venous thrombosis.
    Barcellona D, Fenu L, Cauli C, Pisu G, Marongiu F.
    Thromb Haemost; 2003 Dec 25; 90(6):1061-4. PubMed ID: 14652637
    [Abstract] [Full Text] [Related]

  • 7. Prothrombin polymorphism A19911G, factor V HR2 haplotype A4070G, and plasminogen activator-inhibitor-1 polymorphism 4G/5G and the risk of retinal vein occlusion.
    Kuhli-Hattenbach C, Hellstern P, Nägler DK, Kohnen T, Hattenbach LO.
    Ophthalmic Genet; 2017 Dec 25; 38(5):413-417. PubMed ID: 28085526
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The role of plasminogen activator inhibitor-1 polymorphism, factor-V-Leiden, and prothrombin-20210 mutations in pulmonary thromboembolism.
    Oguzulgen IK, Yilmaz E, Demirtas S, Erkekol FO, Ekim N, Demir N, Numanoglu N, Ozel D, Ulu A, Akar N.
    Clin Appl Thromb Hemost; 2009 Feb 25; 15(1):73-7. PubMed ID: 18160588
    [Abstract] [Full Text] [Related]

  • 11. Thrombophilic risk factors and homocysteine levels in Behçet's disease in eastern Spain and their association with thrombotic events.
    Ricart JM, Vayá A, Todolí J, Calvo J, Villa P, Estellés A, España F, Santaolaria M, Corella D, Aznar J.
    Thromb Haemost; 2006 Apr 25; 95(4):618-24. PubMed ID: 16601831
    [Abstract] [Full Text] [Related]

  • 12. Association of allelic variants of factor V Leiden, prothrombin and methylenetetrahydrofolate reductase with thrombosis or ocular involvement in Behçet's disease: a systematic review and meta-analysis.
    Chamorro AJ, Marcos M, Hernández-García I, Calvo A, Mejia JC, Cervera R, Espinosa G.
    Autoimmun Rev; 2013 Mar 25; 12(5):607-16. PubMed ID: 23207285
    [Abstract] [Full Text] [Related]

  • 13. Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin.
    Espinosa G, Font J, Tàssies D, Vidaller A, Deulofeu R, López-Soto A, Cervera R, Ordinas A, Ingelmo M, Reverter JC.
    Am J Med; 2002 Jan 25; 112(1):37-43. PubMed ID: 11812405
    [Abstract] [Full Text] [Related]

  • 14. Association between plasminogen activator inhibitor 1 gene polymorphisms and preeclampsia.
    Fabbro D, D'Elia AV, Spizzo R, Driul L, Barillari G, Di Loreto C, Marchesoni D, Damante G.
    Gynecol Obstet Invest; 2003 Jan 25; 56(1):17-22. PubMed ID: 12867763
    [Abstract] [Full Text] [Related]

  • 15. Analysis of thrombophilic genetic mutations in patients with Sheehan's syndrome: is thrombophilia responsible for the pathogenesis of Sheehan's syndrome?
    Gokalp D, Tuzcu A, Bahceci M, Ayyildiz O, Yurt M, Celik Y, Alpagat G.
    Pituitary; 2011 Jun 25; 14(2):168-73. PubMed ID: 21107737
    [Abstract] [Full Text] [Related]

  • 16. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
    Aznar J, Vayá A, Estellés A, Mira Y, Seguí R, Villa P, Ferrando F, Falcó C, Corella D, España F.
    Haematologica; 2000 Dec 25; 85(12):1271-6. PubMed ID: 11114134
    [Abstract] [Full Text] [Related]

  • 17. MTHFR C677TT, PAI1 4G-4G, V Leiden Q506, and prothrombin G20210A in hepatocellular carcinoma with and without portal vein thrombosis.
    D'Amico M, Pasta L, Sammarco P.
    J Thromb Thrombolysis; 2009 Jul 25; 28(1):70-3. PubMed ID: 18618228
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The A -844G polymorphism in the PAI-1 gene is associated with a higher risk of venous thrombosis in factor V Leiden carriers.
    Morange PE, Henry M, Tregouët D, Granel B, Aillaud MF, Alessi MC, Juhan-Vague I.
    Arterioscler Thromb Vasc Biol; 2000 May 25; 20(5):1387-91. PubMed ID: 10807758
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.